| 1 |
Proteomics of skeletal muscle glycolysis |
|
| | Ohlendieck, K. | | | Biochimica et Biophysica Acta - Proteins and Proteomics. 2010; 1804(11): 2089-2101 | | | [Pubmed] [Google Scholar] | | | 2 |
Progress in therapeutic antisense applications for neuromuscular disorders |
|
| | Annemieke Aartsma-Rus, Gert-Jan B van Ommen | | | European Journal of Human Genetics. 2010; 18(2): 146-153 | | | [Pubmed] [Google Scholar] | | | 3 |
Proteomics of skeletal muscle differentiation, neuromuscular disorders and fiber aging |
|
| | Ohlendieck, K. | | | Expert Review of Proteomics. 2010; 7(2): 283-296 | | | [Pubmed] [Google Scholar] | | | 4 |
Gene changes in Duchenne muscular dystrophy: Comparison of multiplex PCR and multiplex ligation-dependent probe amplification techniques |
|
| | Kohli, S., Saxena, R., Thomas, E., Singh, J., Verma, I.C. | | | Neurology India. 2010; 58(6): 852-856 | | | [Pubmed] [Google Scholar] | | | 5 |
Proteomic profiling of x-linked muscular dystrophy |
|
| | Caroline Lewis, Steven Carberry, Kay Ohlendieck | | | Journal of Muscle Research and Cell Motility. 2009; 30(7-8): 267 | | | [HTML Full text] [Google Scholar] | | | 6 |
Therapy for neuromuscular disorders |
|
| | Arnett, A.L., Chamberlain, J.R., Chamberlain, J.S. | | | Current Opinion in Genetics and Development. 2009; 19(3): 290-297 | | | [Pubmed] [Google Scholar] | |
|
